Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fatemeh Ghazizadeh-Hashemi"'
Autor:
Alireza Hashemi, Hassan Hashemi, Alireza Jamali, Hamed Ghasemi, Fatemeh Ghazizadeh Hashemi, Mehdi Khabazkhoob
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract To determine the association between visual impairment (VI) and some mental disorders using the general health questionnaire (GHQ) in individuals aged 60 years and above in Tehran, Iran. The present population-based cross-sectional study was
Externí odkaz:
https://doaj.org/article/d47467a2204a494cbdf3b5880917e2d5
Autor:
Fatemeh Shahamat Dehsorkh, Fataneh Ghadirian, Yeganeh Yekta, Reihaneh Yekta, Mohsen Foroughipour, Fatemeh Ghazizadeh Hashemi, Mehrdad Esmaeili, Mehdi Khabazkhoob
Publikováno v:
Iranian Journal of Psychiatry, Vol 18, Iss 1 (2022)
Objective: This study was designed to compare object relations and anger control between MS patients and normal individuals. Method: The present study was a cross-sectional case-control study with two groups: the case group (patients with MS) and
Externí odkaz:
https://doaj.org/article/2475ef2c677843c1bd44fdaf71902ff1
Autor:
Kamyar Moradi, Amir Ashraf-Ganjouei, Fatemeh Ghazizadeh-Hashemi, Nazila Shahmansouri, Shahin Akhondzadeh, Sayna Bagheri, Maryam Mehrpooya, Ahmad Ali Noorbala
Publikováno v:
Psychiatry and Clinical Neurosciences. 75:250-255
AIM Depression has been recognized as one of the disorders associated with cardiac interventions such as percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG). In the present study, we evaluated the efficacy and safe
Autor:
Mohammad Arbabi, Shahin Akhondzadeh, Hossein Sanjari Moghaddam, Fatemeh Ghazizadeh-Hashemi, Sara Momtazmanesh, Seyyede-Ozra Yasrebi, Nazila Shahmansouri, Maryam Mehrpooya
Publikováno v:
Journal of psychosomatic research. 150
Near one-fifth of patients with coronary artery disease (CAD) develop major depressive disorder (MDD), an independent risk factor of mortality in these patients. We investigated the efficacy of oral pentoxifylline in treating MDD in CAD patients unde
Autor:
Alireza Ghajar, Mohsen Afarideh, Mehrdad Eftekhar Ardebili, Mohammadreza Shalbafan, Fatemeh Ghazizadeh-Hashemi, Shahin Akhondzadeh, Ali Ghaleiha, Maryam Ghazizadeh-Hashemi, Farzaneh Malekpour
Publikováno v:
Journal of Affective Disorders. 232:127-133
Background Experimental studies provide evidence for antidepressant effects of Palmitoylethanolamide (PEA) in animal models of depression. We aimed to evaluate the efficacy and tolerability of PEA add-on therapy in treatment of patients with major de